PassionBio.tech’s Agile Advisors are pleased to welcome Alexander (Sascha) Helmstedt and Maximilian Graf v. Preysing-Lichtenegg-Moos to the team.
Both are currently pursuing university studies at the intersection of data science, life sciences, and economics. Despite their early career stage, they have already gained substantial exposure to the industry, particularly through direct engagement in client projects. Their prior experience includes both technology-focused service delivery and independent client acquisition and advisory work.
At PassionBio.tech, they are supporting data management and project coordination across our strongly international pipeline. Of the 28 projects engaged with in recent months, 11 originated from Asia, including Hong Kong and Taiwan. Sascha and Maximilian are helping to structure this pipeline and build a knowledge base to support future growth.
Their work contributes to both of PBTech’s core business areas:
M&A Advisory:
• Small, niche-market players with high EBITDA margins
• Companies with high growth potential, becoming attractive to institutional and industrial investors
• Companies open to investments, including smaller equity ticket sizes
• Underperforming companies requiring strategic and operational turnaround for relaunch and growth
Venture Building – some of our core expertise includes:
• Cell-based production systems and automation solutions with human and veterinary applications
• AI-driven tools for target identification and virtual screening of drug candidates
• Material science applications with medical or diagnostic relevance
• Clinical and commercial production of vaccines and biologics
We are glad to have them on board. For collaboration opportunities, reach out to us at agile.advisor@passionbio.tech
